EUVIMEDEUVIMED entdecken
Leserbrief

Quantitative assessment of minimal residual disease for monitoring of paediatric patients with relapsed/refractory anaplastic large‐cell lymphoma treated with brentuximab vedotin: A case series

Giorgia Contarini, Elisa Carraro, Federica Lovisa, Gaia Martire, Luca Lo Nigro iD, Alessandra Sala, Marta Pillon iD, Lara Mussolin iD

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19151 ↗

Kurz gefasst

Leserbrief in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Giorgia Contarini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Maternal and Child Health Department Pediatric Hematology, Oncology and Stem Cell Transplant Center, University of Padua, Padua, Italy. Hauptthemen laut MEDLINE: Lymphoma, Large-Cell, Anaplastic, Hodgkin Disease, Immunoconjugates. Die Arbeit nennt 15 Literaturangaben. Gefördert von: AIRC by Associazione Italiana per la Ricerca sul Cancro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large-Cell, AnaplasticHodgkin DiseaseImmunoconjugatesHumansChildBrentuximab VedotinNeoplasm, ResidualNeoplasm Recurrence, Local

Substanzen

Brentuximab VedotinImmunoconjugates

Autor:innen und Institutionen

  • Maternal and Child Health Department Pediatric Hematology, Oncology and Stem Cell Transplant Center, University of Padua, Padua, Italy.
  • Pediatric Research Institute "Città della Speranza", Padua, Italy.
  • Center of Pediatric Hematology-Oncology, Azienda Policlinico-San Marco, Catania, Italy.
  • Department of Pediatric Hematology Oncology, Fondazione IRCCS San Gerardo dei Tintori, Centro Maria Letizia Verga, University of Milano-Bicocca, Monza, Italy.

ORCID-Profile: Luca Lo Nigro, Marta Pillon, Lara Mussolin

Förderung

  • AIRC by Associazione Italiana per la Ricerca sul Cancro

Zitieren

APA

Contarini, G., Carraro, E., Lovisa, F., Martire, G., Lo Nigro, L., Sala, A., Pillon, M., & Mussolin, L. (2024). Quantitative assessment of minimal residual disease for monitoring of paediatric patients with relapsed/refractory anaplastic large‐cell lymphoma treated with brentuximab vedotin: A case series. British Journal of Haematology. https://doi.org/10.1111/bjh.19151

Vancouver

Contarini G, Carraro E, Lovisa F, Martire G, Lo Nigro L, Sala A, et al. Quantitative assessment of minimal residual disease for monitoring of paediatric patients with relapsed/refractory anaplastic large‐cell lymphoma treated with brentuximab vedotin: A case series. British Journal of Haematology. 2024. doi:10.1111/bjh.19151

BibTeX
@article{Contarini2024,
  author = {Contarini, Giorgia and Carraro, Elisa and Lovisa, Federica and Martire, Gaia and Lo Nigro, Luca and Sala, Alessandra and Pillon, Marta and Mussolin, Lara},
  title = {Quantitative assessment of minimal residual disease for monitoring of paediatric patients with relapsed/refractory anaplastic large‐cell lymphoma treated with brentuximab vedotin: A case series},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19151}
}
Kostenlos starten →